U. Researcher Receives a $100,000 Grant
Posted on: Monday, 20 February 2006, 15:00 CST
University of Utah cancer researcher Lewis Charles Murtaugh, Ph.D. has just been awarded a one-year $100,000 grant from the Lustgarten Foundation for Pancreatic Cancer Research.
Pancreatic cancer is the fourth most fatal cancer among men and women. More than 30,000 Americans are diagnosed each year. Pancreatic cancer is also highly resistant to current chemotherapy and radiation treatments, and is often detected too late for surgery to help. The grants will help researchers explore cutting edge technology and novel ideas to improve the diagnosis, treatment and prevention of this disease.
Murtaugh, an assistant professor of Human Genetics at the U., is researching "Interdependence of Notch and K-ras Signaling in Pancreatic Tumorigenesis."
Source: Deseret News (Salt Lake City)
Related Articles
- Asuragen Launches The First Validated microRNA Diagnostic Assay
- Aida's Phase II Testing for Anticancer Drug Shows Strong Efficacy
- Gene therapy tested in pancreatic cancer studies
- November is Pancreatic Cancer Awareness Month
- Pancreatic Cancer Action Network (PanCAN) Rolls Out the Red Carpet for NBC's Today Show Host Katie Couric and Honors ABC's Extreme Makeover: Home Edition, Among Others
- City Docs Lead Fight on Cancer; Fresh Hope Against Disease
- 'Bidding for a Cure 2005' in NYC on Nov. 17 Benefits Pancreatic Cancer Research & Awareness
- Processed Meat Consumption Results in 6700% Increase in Pancreatic Cancer Risk Due to Chemical Additives, Says Truth Publishing Author
- Utah Jazz to Raise Money and Awareness for Pancreatic Cancer at Opening Game With LA Lakers on Nov. 3
- Internalization of Luminescent Calcium Phosphate Nanoparticles By Human Cancerous Pancreatic Ductal Cells (Capan-1 Line)
User Comments (0)

RSS Feeds